About the Company
We do not have any company description for HeartBeam, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on HeartBeam, Inc.
HeartBeam, Inc. (NASDAQ:BEAT) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript August 13, 2025 HeartBeam, Inc. beats earnings expectations. Reported EPS is $-0.15, ...
HeartBeam Inc (BEAT) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Financial Discipline
HeartBeam Inc (BEAT) showcases FDA clearances and innovation while managing cash burn and preparing for commercialization.
Earnings To Watch: HeartBeam Inc (BEAT) Reports Q2 2025 Result
HeartBeam Inc (NASDAQ:BEAT) is set to release its Q2 2025 earnings on Aug 13, 2025. The consensus estimate for Q2 2025 ...
HeartBeam Advances Toward ECG Software Commercialization
Heartbeam, Inc. ( ($BEAT) ) has released its Q2 earnings. Here is a breakdown of the information Heartbeam, Inc. presented to its investors.
Biomednewsbreaks Heartbeam Inc. (NASDAQ: BEAT) Reports Q2 2025 Results, Advances Toward FDA Clearance And Commercial Launch
HeartBeam (NASDAQ: BEAT) , a medical technology company developing personalized cardiac care solutions, reported financial and operational results fo ...
HeartBeam, Inc. (BEAT) Q1 2023 Earnings Call Transcript
HeartBeam, Inc. (NASDAQ:BEAT) Q1 2023 Earnings Conference Call May 11, 2023 6:00 PM ETCompany ParticipantsBranislav Vajdic - Founder and Chief Executive ...
HeartBeam Announces Automated Cardiac Detection Patent Granted for ...
About HeartBeam, Inc. HeartBeam, Inc. (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only 3D-vector ECG platform intended for patient use at home.
Multiple insiders bought HeartBeam, Inc. (NASDAQ:BEAT) stock earlier ...
Insiders at HeartBeam Have Bought Stock Recently Over the last three months, we've seen a bit of insider buying at HeartBeam. Chief Financial Officer Richard Brounstein shelled out US$17k for ...
What's Going On With Heartbeam (BEAT) Stock?
Heartbeam shares are trading higher by 3.5% to $2.35 Tuesday, pulling back following the session high of $2.70. The company last week said it secured two new patents.
HeartBeam Broadens Product Portfolio Pipeline with Smartwatch ...
HeartBeam, Inc., a cardiac technology company that has developed the first and only 3 D-vector ECG platform for heart attack detection anytime, anywhere, announced today the expansion of its ...
HeartBeam Granted Patent for 12-Lead Electrocardiogram (ECG) Patch ...
About HeartBeam, Inc. HeartBeam, Inc. (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere.
HeartBeam, Inc. (BEAT) Q2 2023 Earnings Call Transcript
HeartBeam, Inc. (NASDAQ: BEAT) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Branislav Vajdic - Founder & Chief Executive Officer Robert Eno - President Richard ...
Similar Companies
Loading the latest forecasts...